Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
11/2014
11/04/2014US8877766 Neuroprotective multifunctional antioxidants and their monofunctional analogs
11/04/2014US8877757 Pyrazine derivatives and use as PI3K inhibitors
11/04/2014US8877753 1-aryl-3-aminoalkoxy pyrazoles as sigma ligands enhancing analgesic effect of opioids and attenuating the dependency thereof
11/04/2014US8877752 4(1H)-quinolones having antimalarial activity with reduced chemical resistance
11/04/2014US8877749 Spirocyclic compounds as modulators of chemokine receptor activity
11/04/2014US8877747 Indenone derivative and pharmaceutical composition comprising same
11/04/2014US8877745 CCR2 receptor antagonists, method for producing the same, and use thereof as medicaments
11/04/2014US8877741 Pyrrolidine derivatives, pharmaceutical compositions and uses thereof
11/04/2014US8877707 Inhibitors of HCV NS5A
11/04/2014US8877315 Indolium compound and optical recording material containing the same
10/2014
10/30/2014US20140323734 Method for the Preparation of N-Oxyl Hindered Amine Inhibitors
10/30/2014US20140323733 Diamide compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
10/30/2014US20140323729 Pyruvate kinase m2 modulators, therapeutic compositions and related methods of use
10/30/2014US20140323725 Processes of synthesizing dihydropyridophthalazinone derivatives
10/30/2014US20140323724 Process for producing substituted methylamine compound and triazine derivative
10/30/2014US20140323494 N-oxides of n-phenyl-2-pyrimidine-amine derivatives
10/30/2014US20140323492 Ccr2 receptor antagonists
10/30/2014US20140323490 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
10/30/2014US20140323486 Heterocyclic urea compounds
10/30/2014US20140323485 N-Substituted Heterocyclyl Carboxamides
10/30/2014US20140323484 Pharmaceutically Active Pyrazine Derivatives
10/30/2014US20140323483 Type iii secretion inhibitors, analogs and uses thereof
10/30/2014US20140323470 Kinase inhibitors
10/30/2014US20140323467 Therapeutic compounds and compositions
10/30/2014US20140323464 Kinase inhibitors
10/30/2014US20140323463 Pyrazinecarboxamide compound
10/30/2014US20140323461 Phenyl-Substituted Nicotinic Ligands, and Methods of Use Thereof
10/30/2014US20140323458 Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating hcv infections
10/30/2014US20140323448 sGC STIMULATORS
10/30/2014US20140323447 Heteroaromatic compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof
10/30/2014US20140323418 Selective kinase inhibitors
10/30/2014US20140323412 Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease
10/30/2014US20140322355 Heterocyclic modulators of lipid synthesis
10/30/2014US20140322195 Factor IXA Inhibitors
10/30/2014US20140322165 Inhibitors of hepatitis c virus polymerase
10/30/2014US20140322128 Materials and Methods Useful to Induce Cell Death via Methuosis
10/28/2014US8872422 Dinaphthyl ethylene derivativce, process for preparing it, film prepared from it, and OLED including the film
10/28/2014US8871946 Benzimidazole-4-carboxamide derivatives, their preparation methods, pharmaceutical compositions and their uses
10/28/2014US8871942 Process for producing 1-triazole-2-butanol derivatives
10/28/2014US8871940 Unsymmetrical bisazides for chemoselective sequential ligation
10/28/2014US8871939 Method for preparing 2-aminobenzamide derivatives
10/28/2014US8871938 Process for making quinolone compounds
10/28/2014US8871937 8-hydroxy-quinoline derivatives
10/28/2014US8871930 Preparation method of alpha-imatinib mesylate
10/28/2014US8871929 Fused-imidazoyl compounds useful as antimicrobial agents
10/28/2014US8871796 Diaryl ether derivatives as notch sparing gamma secretase inhibitors
10/28/2014US8871790 Heterocyclic modulators of lipid synthesis
10/28/2014US8871788 Substituted N-alkyl and N-acyl tetrahydro-isoquinoline derivatives, preparation and therapeutic use thereof
10/28/2014US8871782 Alkoxy substituted imidazoquinolines
10/28/2014US8871778 Substituted pyrimidine compounds and their use as SYK inhibitors
10/28/2014US8871777 Phenylpyrimidone compounds, the pharmaceutical compositions, preparation methods and uses thereof
10/28/2014US8871775 Compounds
10/28/2014US8871774 Inhibitors of influenza viruses replication
10/28/2014US8871771 Salts of prodrugs of piperazine and substituted piperidine antiviral agents
10/28/2014US8871770 Carboxamide compounds and methods for using the same
10/28/2014US8871769 Ureas and their use in the treatment of heart failure
10/28/2014US8871766 Heterocyclic compounds
10/28/2014US8871765 Substituted 4-(4-fluoro-3-(piperazine-1-carbonyl)benzyl)phthalazin-1(2H)-one derivatives as poly (ADP-ribose) polymerase-1 inhibitors
10/28/2014US8871756 Compounds for the treatment and prophylaxis of Respiratory Syncytial Virus disease
10/28/2014US8871746 Antiviral drugs for treatment of arenavirus infection
10/28/2014US8871187 Oxoazetidine derivatives, process for the preparation thereof and use thereon in human medicine and in cosmetics
10/23/2014US20140316130 Use of microfabricated devices
10/23/2014US20140315957 Androgen receptor antagonists and uses thereof
10/23/2014US20140315956 Small molecule inhibitors of il-6 and uses thereof
10/23/2014US20140315949 Modulators of methyl modifying enzymes, compositions and uses thereof
10/23/2014US20140315944 Substituted naphthyridine and quinoline compounds as mao inhibitors
10/23/2014US20140315934 Substituted benzylpyrazoles
10/23/2014US20140315932 Quinazolinone derivatives useful as vanilloid antagonists
10/23/2014US20140315928 Substituted amide compounds
10/23/2014US20140315925 5-(Pyridin-2-yl-Amino)-Pyrazine-2-Carbonitrile Compounds and Their Therapeutic Use
10/23/2014US20140315924 Sulfonic acid salts of heterocyclylamide-substituted imidazoles
10/23/2014US20140315923 Substituted n-heteroaryl spirolactam bipyrrolidines, preparation and therapeutic use thereof
10/23/2014US20140315917 Imidazolidinones and analogs exhibiting anti-cancer and anti-proliferative activities
10/23/2014US20140315914 Carbamate-substituted oxindole derivatives and use thereof for the treatment of vasopressin-dependent diseases
10/23/2014US20140315913 Substituted pyridine and pyrazine compounds as pde4 inhibitors
10/23/2014US20140315912 Novel pyrrolidine derived beta 3 adrenergic receptor agonists
10/23/2014US20140315906 4-aryl-n-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group
10/23/2014US20140315904 Arginine methyltransferase inhibitors and uses thereof
10/23/2014US20140315903 1, 4-Disubstituted 3-Cyano-Pyridone Derivatives and Their Use As Positive Allosteric Modulators of MGLUR2-Receptors
10/23/2014US20140315893 1,4- dihydropyridine derivatives with hsp modulating activity
10/23/2014US20140315889 Hydroxamate derivatives for hdac inhibitor, and the pharmaceutical composition comprising thereof
10/23/2014US20140315886 Quinazolines as therapeutic compounds and related methods of use
10/23/2014US20140315884 Ampk-activating heterocyclic compounds and methods for using the same
10/23/2014US20140315881 Compounds and methods
10/23/2014US20140315879 Sulfonamide Derivatives
10/23/2014US20140315878 Chemical compounds
10/23/2014US20140315857 N- (4 -quinolinylmethyl) sulfonamide derivatives and their use as anthelmintics
10/23/2014US20140315856 Aminopyrazole derivative
10/23/2014US20140315845 Hsp90 inhibitors with modified toxicity
10/23/2014US20140315721 Pesticidal compositions and processes related thereto
10/23/2014US20140314785 Compositions and methods for inhibition of the jak pathway
10/21/2014US8865912 Benzimidazole derivatives as PI3 kinase inhibitors
10/21/2014US8865911 Compounds and their use as BACE inhibitors
10/21/2014US8865906 Process for the preparation of a compound useful as an inhibitor of TAFIa
10/21/2014US8865901 Gain-of-function Bcl-2 inhibitors
10/21/2014US8865899 Chemical process for the synthesis of 4-(4-bromo-2-fluoroanilino)-6-methoxy-7-(1-methylpiperidin-4-ylmethoxy)quinazoline
10/21/2014US8865894 Oxazolidin-2-one compounds and uses thereof
10/21/2014US8865755 Dual-acting antihypertensive agents
10/21/2014US8865745 Pyrazolone derivatives as PDE4 inhibitors
10/21/2014US8865739 Substituted heterocyclic compounds as ion channel modulators
1 ... 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 ... 1080